Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

<i>Tet2</i> and <i>Jak2</i> clonal hematopoiesis do not modify murine tauopathy.

Journal of Alzheimer's disease : JAD·2026
Same author

ASO Author Reflections: Redefining Breast-Conserving Therapy: National Trends in Oncoplastic Reconstruction.

Annals of surgical oncology·2026
Same author

Mutation-dependent responses to sleep and exercise in clonal haematopoiesis.

Nature·2026
Same author

Generation of ciBMECs: Endothelial Cells Acquire Blood-Brain Barrier Identity and Function Through Wnt Activation.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

ASO Visual Abstract: Assessing Recent Trends in Lumpectomy and Concomitant Oncoplastic Procedures: A National Insurance Database Analysis.

Annals of surgical oncology·2026
Same author

Reprogramming the diseased liver: antioxidant-engineered mRNA nanoparticles as microenvironment modulators in MAFLD.

Immunometabolism (Cobham, Surrey)·2026
Same journal

Overcoming the Catalytic Bucket Effect in Pt-based High-Entropy Nanocages Through Interface Defect and Strain Engineering.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Rare-Earth-Sulfur Surface Modification Enables SiC Ceramics for Low-Frequency Electromagnetic Wave Absorption in Extreme Environments.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

PFKFB4 Deubiquitination by USP10 Enhances Fumarate Metabolism to Orchestrate the KDM1A/Rad51 Axis and Confer Radioresistance in Lung Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Assessing Strengths and Limitations of Magnetoencephalography Source Imaging With Intracerebral EEG.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Efficient Adsorption-Based Direct Air Capture Via Triply Periodic Minimal Surface Architectures.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Inhalable ROS-Responsive Nanospray Activates PPAR-γ to Restore Macrophage Mitochondrial Homeostasis and Attenuate Radiation-Induced Lung Injury.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
查看所有相关文章

相关实验视频

Updated: Jan 18, 2026

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
06:03

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

9.6K

一个系统选择性修改的mRNA输送平台,用于预防化疗诱导的心脏毒性.

Jimeen Yoo1,2,3, Gayatri Mainkar1,2,3, Matteo Ghiringhelli1,2,3

  • 1Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|January 16, 2026
PubMed
概括
此摘要是机器生成的。

这项研究引入了一种新的mRNA疗法平台 (cmSMRTs),用于最小侵入性,针对性地向心脏输送. 它有效地预防化疗引起的心脏毒性,而不会影响抗瘤疗效.

关键词:
多克斯心脏毒性心脏选择性输送 - 心脏选择性输送修改后的mRNA是什么

更多相关视频

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.9K
Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.6K

相关实验视频

Last Updated: Jan 18, 2026

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
06:03

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

9.6K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.9K
Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.6K

科学领域:

  • 心脏病学 心脏病学
  • 在瘤学瘤学.
  • 生物技术是生物技术.

背景情况:

  • 多克索鲁比 (Dox) 化疗导致剂量依赖的心脏毒性,限制了其临床使用.
  • doxorubicin 诱导的心脏毒性涉及氧化应激和胺在心肌细胞中的积累.
  • 目前的mRNA疗法需要侵入性输送,这阻碍了广泛应用.

研究的目的:

  • 开发一种最小侵入性,心脏选择性的mRNA输送系统,以预防多克索鲁比诱导的心脏毒性.
  • 评估在临床前模型中通过新平台传递的酸胺酶 (AC) 修改的mRNA (modRNA) 的疗效.

主要方法:

  • 开发了一种心脏选择性mRNA转化系统 (cmSMRTs),使用脂质纳米粒子进行静脉输送.
  • 利用微RNA引导的翻译控制 (miR143和miR122) 来提高心脏向性和减少非向性表达.
  • 在实验室中评估了AC modRNA的疗效,使用Doxorubicin治疗的人类诱导的多能干细胞衍生的心肌细胞.
  • 在老鼠模型中评估了cmSMRTs143-122的慢性多克索鲁比辛诱导的心脏毒性.

主要成果:

  • 在体外,AC治疗保留了心肌细胞结构,处理和线粒体功能.
  • 通过cmSMRTs静脉输入AC modRNA可以预防多克索鲁比治疗小鼠的心脏功能障碍,纤维化和缩.
  • 该疗法证明了心脏选择性,而不会影响多克索鲁比的抗瘤疗效或整体毒性.

结论:

  • cmSMRTs 143-122代表了一个有前途的,微创的mRNA疗法平台,用于预防化疗诱导的心脏毒性.
  • 这种方法提供了一个潜在的策略,以提高多克索鲁比治疗的安全性和耐受性.
  • 这项研究突出了针对性mRNA传递在癌症患者治疗相关毒性管理方面的潜力.